يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"primary chemosensitivity"', وقت الاستعلام: 1.51s تنقيح النتائج
  1. 1
    دورية أكاديمية
    The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review

    المؤلفون: Ambroise Lauby, Olivier Colomban, Pauline Corbaux, Julien Peron, Lilian Van Wagensveld, Witold Gertych, Naoual Bakrin, Pierre Descargues, Jonathan Lopez, Vahan Kepenekian, Olivier Glehen, Charles Andre Philip, Mojgan Devouassoux-Shisheboran, Michel Tod, Gilles Freyer, Benoit You

    المصدر: Cancers, Vol 14, Iss 1, p 98 (2021)

    مصطلحات موضوعية: ovarian cancer, KELIM, CA-125, primary chemosensitivity, treatment success, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/14/1/98; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/a2929bd7a3ec45a7b50b8e37fc9ad34a

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  3. 3
    The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer

    المصدر: Cancers. 14(1)

    مصطلحات موضوعية: EPITHELIAL OVARIAN, primary chemosensitivity, CARBOPLATIN, KELIM, PHASE-III TRIAL, treatment success, RANDOMIZED CLINICAL-TRIAL, NEOADJUVANT CHEMOTHERAPY, 1ST-LINE TREATMENT, FALLOPIAN-TUBE, ovarian cancer, CA-125, PRIMARY SURGERY, EXPLORATORY ANALYSIS, PROGRESSION-FREE SURVIVAL

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=od________83::582bc17d186e142c45ce6e5df193f697
    https://doi.org/10.3390/cancers14010098

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review.

    المؤلفون: Lauby A; Oncology Department, CITOHL, Lyon-Sud Hospital, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Hospices Civils de Lyon, 69495 Lyon, France., Colomban O; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France., Corbaux P; Oncology Department, CITOHL, Lyon-Sud Hospital, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Hospices Civils de Lyon, 69495 Lyon, France., Peron J; Oncology Department, CITOHL, Lyon-Sud Hospital, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Hospices Civils de Lyon, 69495 Lyon, France.; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France., Van Wagensveld L; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.; GROW, School for Oncology and Developmental Biology, Maastricht University, 6200 MD Maastricht, The Netherlands., Gertych W; Department of Gynecological Surgery, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Bakrin N; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France.; Departement of Surgical Oncology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Descargues P; Department of Gynecological Surgery, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Lopez J; Biochemistry and Molecular Biology Department, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Kepenekian V; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France.; Departement of Surgical Oncology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Glehen O; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France.; Departement of Surgical Oncology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Philip CA; Croix Rousse Hospital, Hospices Civils de Lyon, 69004 Lyon, France., Devouassoux-Shisheboran M; Department of Pathology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Lyon, France., Tod M; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France.; Hospices Civils de Lyon, Pharmacie, Croix Rousse Hospital, Hospices Civils de Lyon, 69004 Lyon, France., Freyer G; Oncology Department, CITOHL, Lyon-Sud Hospital, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Hospices Civils de Lyon, 69495 Lyon, France.; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France., You B; Oncology Department, CITOHL, Lyon-Sud Hospital, Cancer Institute of Hospices Civils de Lyon (IC-HCL), Hospices Civils de Lyon, 69495 Lyon, France.; Lyon-Sud Medicine School, University of Lyon, University Claude Bernard Lyon 1, 69008 Lyon, France.

    المصدر: Cancers [Cancers (Basel)] 2021 Dec 25; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 25.

    نوع المنشور: Journal Article; Review

    بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء